Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

Fuso Pharmaceutical Industries Ltd (4538)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
2,213.0 -34.0    -1.51%
02/05 - Closed. Currency in JPY ( Disclaimer )
Type:  Equity
Market:  Japan
ISIN:  JP3823600006 
  • Volume: 5,400
  • Bid/Ask: 2,205.0 / 2,223.0
  • Day's Range: 2,210.0 - 2,244.0
Fuso Pharmaceutical 2,213.0 -34.0 -1.51%

4538 Balance Sheet

 
Featured here, the Balance Sheet for Fuso Pharmaceutical Industries Ltd, which summarizes the company's financial position including assets, liabilities and shareholder equity for each of the latest 4 period ending dates (either quarterly or annually).
AnnualQuarterly
InvestingPro Advanced Balance Sheet
Period Ending: 2022
31/03
2021
31/12
2021
30/09
2021
30/06
Total Current Assets 39787 41403 40907 39937
Cash and Short Term Investments 7347 8238 8677 7459
Cash - - - -
Cash & Equivalents 7347 8238 8677 7459
Short Term Investments - - - -
Total Receivables, Net 21152 22696 21495 21415
Accounts Receivables - Trade, Net 20850 22696 21495 21415
Total Inventory 10510 9575 9912 10217
Prepaid Expenses 221 - - -
Other Current Assets, Total 557 894 823 846
Total Assets 69334 70954 70575 69686
Property/Plant/Equipment, Total - Net 23792 23938 24285 24406
Property/Plant/Equipment, Total - Gross 76078 8818 8818 8818
Accumulated Depreciation, Total -52287 - - -
Goodwill, Net - - - -
Intangibles, Net 453 520 224 273
Long Term Investments 3093 - - -
Note Receivable - Long Term 5 - - -
Other Long Term Assets, Total 2204 5093 5159 5070
Other Assets, Total - - - -
Total Current Liabilities 26375 26987 26443 26584
Accounts Payable 13227 13283 12656 12206
Payable/Accrued - - - -
Accrued Expenses 1332 451 890 445
Notes Payable/Short Term Debt 2350 6753 6267 6656
Current Port. of LT Debt/Capital Leases 3586 - - -
Other Current liabilities, Total 5880 6500 6630 7277
Total Liabilities 34802 36366 36226 35937
Total Long Term Debt 5758 6705 7102 6572
Long Term Debt 5758 6705 7102 6572
Capital Lease Obligations - - - -
Deferred Income Tax 1315 - - -
Minority Interest - - - -
Other Liabilities, Total 1354 2674 2681 2781
Total Equity 34532 34588 34349 33749
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total 10758 10758 10758 10758
Additional Paid-In Capital 15009 15009 15009 15010
Retained Earnings (Accumulated Deficit) 14731 14743 14555 14059
Treasury Stock - Common -2170 -2170 -2169 -2168
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) -3797 -3753 -3804 -3909
Other Equity, Total 1 1 - -1
Total Liabilities & Shareholders' Equity 69334 70954 70575 69686
Total Common Shares Outstanding 8.77 8.77 8.77 8.77
Total Preferred Shares Outstanding - - - -
* In Millions of (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

4538 Comments

Write your thoughts about Fuso Pharmaceutical Industries Ltd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email